Combination of high dose radiotherapy and immunotherapy in the treatment of glioblastoma

Neurology/Neurosurgery Grand Rounds

Friday, February 14, 2020 at 8:00 AM


This grand round has already taken place.


HSC level 3, lecture hall 6 - Stony Brook, NY
February 14th, 2020
1.00 AMA PRA Category 1 Credit Hours

Description

A discussion on combination of high dose radiotherapy and immunotherapy in the treatment of glioblastoma

Dates and Times

Start: 2/14/2020 8:00 AM
End: 2/14/2020 9:00 AM

Objectives

  • Review current evidence behind combining radiotherapy and immunotherapy for treatment of GBM
  • Present pre-clinical data for novel treatment paradigm
  • Examine potential implications for normal brain tissue toxicity of the combined therapy
  • Present prospective clinical trial to be launched at SBUH

Speakers

  • Dr. Alexander Stessin
    • Combination of high dose radiotherapy and immunotherapy in the treatment of glioblastoma

Location

HSC level 3, lecture hall 6
Stony Brook Medicine
Stony Brook, NY 11794

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Give us a call
(631) 444-2094
Office of Continuing Medical Education
Renaissance School of Medicine at Stony Brook University
HSC, Level 2, Room 142
Stony Brook, New York 11794-8222